Hematology NewsFOUND IN TRANSLATION Minimal nomenclature and maximum sensitivity complicate MRD measuresDecember 22, 2016ALLAMLTranslational Research
Hematology TimesIntermittent fasting fights ALL, not AML, in miceDecember 21, 2016Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesCongenital CMV linked to increased risk of ALLDecember 16, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesPlatform could optimize treatment of ALL, other diseasesDecember 15, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesHow old is too old to be on a kids’ protocol for ALL?December 14, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsGood response from CAR T cells with ‘safety switch’ for advanced ALLDecember 13, 2016ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesGroup estimates global cancer cases, deaths in 2015December 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLALLHodgkin Lymphoma
Hematology NewsAnti-CD22 CAR T-cells shift ALL into complete remissionDecember 4, 2016ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsVIDEO: Anti-CD22 CAR for R/R ALL impresses in early trialDecember 3, 2016ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA grants full approval for ponatinibNovember 30, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesCAR T-cell trial placed on hold againNovember 25, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsPh-like ALL is highly prevalent in adultsNovember 23, 2016ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesALL subtype ‘highly prevalent’ in adultsNovember 22, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesCompany withdraws application for eryaspase in ALLNovember 16, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesTeam develops model of common infant ALLNovember 16, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
